Banzai International, Inc.
PARA Nasdaq Services-Prepackaged Software Financials FY2021βFY2025
What Banzai International, Inc. does
No business description yet.
- Legal name
- Banzai International, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001193125-26-134714
0001826011
Revenue and margins
Banzai International, Inc. had $12.2M of revenue in fiscal 2025, up 168.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Banzai International, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 748.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Banzai International, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.7M | $1.0M | $2.1M | $1.1M | $0.3M |
| Current ratio | 0.6x | 0.0x | 0.1x | 0.1x | 0.1x |
| Quick ratio | 0.6x | 0.0x | 0.1x | 0.1x | 0.1x |
| Total assets | $231M | $5.5M | $5.3M | $25.7M | $31.6M |
| Total liabilities | $21.1M | $29.6M | $37.2M | $28.4M | $23.6M |
| Shareholders' equity | β$15.7M | β$24.1M | β$31.9M | β$2.8M | $8.1M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 8 | 5 / 8 | 4 / 8 |
| Accruals ratio | 5.5% | β8.7% | β238.8% | β141.7% | β23.7% |
| Altman Z'' | β1.16 | β61.08 | β84.54 | β20.11 | β18.30 |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | β | $5.3M | $4.6M | $4.5M | $12.2M |
| Gross profit | β | $3.4M | $3.1M | $3.1M | $10.0M |
| Operating income | β$2.7M | β$6.2M | β$9.8M | β$13.5M | β$18.5M |
| Pretax income | $11.6M | β$15.5M | β$14.4M | β$31.5M | β$22.4M |
| Income tax | β | $0.0M | $0.0M | $0.0M | $0.1M |
| Net income | $11.6M | β$15.5M | β$14.4M | β$31.5M | β$22.5M |
| Net income to common | β | β$15.5M | β$14.4M | β$31.1M | β$22.5M |
| Diluted EPS | β | β$2.40 | β$6.00 | β$69.75 | β$5.95 |
| Diluted shares | β | 0.01B | 0.00B | 0.00B | 0.00B |
| Cash flow | |||||
| Cash from operations | β$1.0M | β$5.2M | β$1.6M | β$9.6M | β$15.7M |
| Capital expenditure | β | $0.0M | $0.0M | β | β |
| Free cash flow | β | β$5.2M | β$1.6M | β | β |
| Depreciation and amortization | β | $0.0M | $0.0M | $0.0M | $1.2M |
| Stock-based compensation | β | $0.8M | $1.2M | $1.2M | $2.7M |
| Acquisitions | β | β | $0.0M | β$0.1M | $0.0M |
| Balance sheet | |||||
| Cash and short-term investments | $0.7M | $1.0M | $2.1M | $1.1M | $0.3M |
| Current assets | $1.0M | $1.4M | $2.9M | $2.7M | $1.4M |
| Current liabilities | $1.5M | $29.3M | $37.1M | $28.3M | $22.4M |
| Property and equipment, net | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Goodwill | $2.2M | $2.2M | $2.2M | $19.0M | $22.0M |
| Intangible assets | β | β | $0.0M | $3.9M | $8.0M |
| Total assets | $231M | $5.5M | $5.3M | $25.7M | $31.6M |
| Total liabilities | $21.1M | $29.6M | $37.2M | $28.4M | $23.6M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | β |
| Shareholders' equity | β$15.7M | β$24.1M | β$31.9M | β$2.8M | $8.1M |
| Margins | |||||
| Gross margin | β | 63.3% | 68.3% | 68.6% | 82.0% |
| Operating margin | β | β116.5% | β214.8% | β297.4% | β151.8% |
| EBITDA margin | β | β116.3% | β214.6% | β296.9% | β142.4% |
| Net margin | β | β290.1% | β315.8% | β696.0% | β184.9% |
| FCF margin | β | β97.1% | β34.0% | β | β |
| Returns | |||||
| Return on capital employed | β1.2% | 26.1% | 30.8% | 520.8% | β199.4% |
| Return on equity | β | β | β | β | β850.2% |
| Return on assets | 5.0% | β13.1% | β267.6% | β203.6% | β78.5% |
| Growth | |||||
| Revenue growth | β | β | β14.5% | β0.7% | 168.6% |
| Net income growth | β | β233.0% | β | β | β |
| Share count change | β | β | β62.7% | β81.4% | 748.6% |
| Financial health | |||||
| Current ratio | 0.6x | 0.0x | 0.1x | 0.1x | 0.1x |
| Quick ratio | 0.6x | 0.0x | 0.1x | 0.1x | 0.1x |
| Capital allocation | |||||
| Capex / revenue | β | 0.2% | 0.0% | β | β |
| Stock comp / revenue | β | 14.4% | 27.3% | 25.7% | 22.0% |
| Quality scores | |||||
| Piotroski F-score | β | β | 5.0 | 5.0 | 4.0 |
| Altman Z'' | β1.2 | β61.1 | β84.5 | β20.1 | β18.3 |
| Accruals ratio | 5.5% | β8.7% | β238.8% | β141.7% | β23.7% |
Source: SEC EDGAR XBRL filings (CIK 0001826011). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.